New insights from the 2026 Trends in Specialty Drug Benefits Report, co-sponsored by Pharmaceutical Strategies Group (PSG) and Genentech, are now available. This year’s report covers the changing priorities, challenges and strategies payers are considering to ensure access to specialty…
Presented by:
Specialty therapies hold enormous clinical potential, but access barriers often prevent patients from starting treatment. Over half of prescriptions for newly launched specialty medications never reach patients, and 100 million prescriptions are abandoned each year across branded therapies. At the…
Presented by:
Pharmacy procurement now sits at the intersection of financial performance, supply chain and regulatory accountability. As margins tighten and shortages persist, leaders can no longer rely on isolated purchasing decisions to protect their organizations. This report outlines a clearer path…
Presented by:
Health systems are entering a new era of cardiology care: one where pharmacy, finance and cardiovascular leaders must work together to improve access to provider-administered medications. But scaling delivery for emerging therapies — such as those for rare cardiac conditions…
Presented by:
Powered by Cencora’s Accelerate Pharmacy Solutions, the Pharmacy Outlook 2026 draws on proprietary survey data from more than 100 health system pharmacy leaders navigating payer restrictions, specialty leakage, infusion expansion, and evolving regulatory pressures. The report offers benchmarks across specialty…
Presented by:
Acute pain management remains fragmented across hospitals and departments. Protocols vary by unit. Teams operate in silos. Nonopioid options are underused. Patients fall through the cracks — especially during transitions of care. Without a coordinated approach, health systems face higher…
Presented by:
Manual inventory processes once cost Texas Children’s Hospital millions annually in drug waste and inefficiencies. To close costly blind spots and gain control over medication use, the system implemented RFID-enabled pharmacy automation. The result: real-time visibility into inventory levels, expiration…
Presented by:
More than 200 industry leaders have spoken: the 2025 Trends in Specialty Drug Benefits Report, co-sponsored by Genentech and Pharmaceutical Strategies Group (PSG), is here. This executive summary captures how payers are resetting specialty drug strategies and what that means…
Presented by:
Manual barcode scanning is prone to missed steps, scan failures and inconsistent replenishment. For pharmacy teams managing hundreds of trays, the inefficiencies add up, draining valuable working hours and compromising safety. That was the case at Pasadena, Calif.-based Huntington Health.…
Presented by:
Technician turnover is above 30%, labor costs are rising, and prescription volumes are projected to grow 10–12% by 2028. Traditional, manual pharmacy models simply can’t keep up. One pharmacy needed 862 FTEs to process 75,000 daily prescriptions manually. With automation?…
Presented by:
